PERRIGO COMPANY PLC Unternehmen Perrigo Company PLC TEL AVIV STOCK EXCHANGE
Aktien
IE00BGH1M568
Pharmazeutika
Kurzporträt
Umsatz nach Geschäftsbereich
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
Consumer Self-Care Americas
63,6
%
| 2 926 | 65,7 % | 2 962 | 63,6 % | +1,24 % |
Consumer Self-Care International
36,4
%
| 1 526 | 34,3 % | 1 693 | 36,4 % | +10,99 % |
Umsatz je Region
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
United States
62,7
%
| 2 870 | 64,5 % | 2 917 | 62,7 % | +1,63 % |
Europe
34,0
%
| 1 445 | 32,5 % | 1 582 | 34,0 % | +9,46 % |
All Other Countries
2,5
%
| 107 | 2,4 % | 116 | 2,5 % | +8,39 % |
Ireland
0,9
%
| 29 | 0,7 % | 41 | 0,9 % | +39,25 % |
Manager
| Manager | Titel | Alter | Seit |
|---|---|---|---|
| Chief Executive Officer | 55 | 30.06.23 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 16.05.22 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.15 |
Ronald Janish
COO | Chief Operating Officer | 58 | 01.01.03 |
Grainne Quinn
CTO | Chief Tech/Sci/R&D Officer | 54 | 01.01.14 |
| Chief Tech/Sci/R&D Officer | 66 | 01.10.06 | |
Bradley Joseph
IRC | Investor Relations Contact | - | - |
Adrian Innergård
PRN | Corporate Officer/Principal | 44 | - |
| Corporate Officer/Principal | 55 | 11.09.23 | |
Robert Willis
HRO | Human Resources Officer | 55 | 01.05.13 |
Aufsichtsräte
| Aufsichtsräte | Titel | Alter | Seit |
|---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 15.12.20 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 06.02.17 |
Bradley Alford
BRD | Director/Board Member | 67 | 06.02.17 |
Donal O'Connor
BRD | Director/Board Member | 73 | 01.11.14 |
Geoffrey Parker
BRD | Director/Board Member | 59 | 07.11.16 |
| Director/Board Member | 61 | 02.05.17 | |
Katherine Doyle
BRD | Director/Board Member | 56 | 29.07.20 |
| Chief Executive Officer | 55 | 30.06.23 | |
Julia Brown
BRD | Director/Board Member | 54 | 01.11. |
| Director/Board Member | 60 | 30.07.22 |
Anteilsklasse
| Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
|---|---|---|---|---|---|
| Aktie A | 1 | 136 320 433 | 135 901 274 ( 99,69 %) | 0 | 99,69 % |
Unternehmenskontakt
Konzerngesellschaften
| Name | Kategorie und Branche |
|---|---|
Rosemont Pharmaceuticals Ltd.
 Rosemont Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rosemont Pharmaceuticals Ltd. develops, manufactures, and supplies oral liquid medicines. Its product categories include anaesthesia, cardiovascular system, central nervous system, endocrine system, gastro-intestinal system, infections malignant disease and immunosuppression, musculoskeletal and joint disease, nutrition and blood, and PEG/NG tube administration guides. The company was founded in 1967 and is headquartered in Leeds, the United Kingdom. |
Pharmaceuticals: Major
|
Omega Pharma Belgium NV
 Omega Pharma Belgium NV Medical DistributorsDistribution Services Part of Perrigo Co. Plc, Omega Pharma Belgium NV is a Belgian pharmaceutical company that supplies pharmaceuticals. The company is based in Nazareth, Belgium. The company was founded in 1977. Christophe van Damme has been the CEO of the company since 2020. |
Medical Distributors
|
Perrigo Investments LLC
 Perrigo Investments LLC Financial ConglomeratesFinance Part of Perrigo Co. Plc, Perrigo Investments LLC functions as an investment holding American company. |
Financial Conglomerates
|
Perrigo Israel Agencies Ltd.
 Perrigo Israel Agencies Ltd. Medical DistributorsDistribution Services Part of Perrigo Co. Plc, Perrigo Israel Agencies Ltd. is an Israeli company that distributes pharmaceutical products. The company is based in Bnei Braq, Israel. |
Medical Distributors
|
Elan Finance Plc
|
Finance/Rental/Leasing
|
Omega Pharma Capital NV
 Omega Pharma Capital NV Financial ConglomeratesFinance Part of Perrigo Co. Plc, Perrigo Capital NV is a company that focuses on encouraging Belgian patients to take proactive control of their health in partnership with pharmacists as central care providers. The company is based in Nazareth, Belgium. The company is brand builders at Perrigo Belgium, placing the Belgian patient at the center of everything they do and creating demand by addressing the patient's needs in a relevant and engaging manner. The company aims to make lives better by bringing quality, affordable self-care products that consumers trust wherever they are sold. The company was founded in 1987, and the CEO is Barbara de Saedeleer. |
Financial Conglomerates
|
Habsont Unlimited Co.
 Habsont Unlimited Co. Finance/Rental/LeasingFinance Part of Perrigo Co. Plc, Habsont Unlimited Co. provides financial leasing services. The company is based in Dublin, Ireland and was founded in 2013. |
Finance/Rental/Leasing
|
Pharmaceuticals: Major
| |
Wrafton Laboratories Ltd.
 Wrafton Laboratories Ltd. Pharmaceuticals: OtherHealth Technology Wrafton Laboratories Ltd. manufactures pharmaceutical products. It supplies medicines, vitamin supplements, herbal medicines and medical devices to the supermarket chains. Wrafton Laboratories Ltd. is a subsidiary of Perrigo Co. The company was founded in 1992 and is headquartered in Braunton, UK |
Pharmaceuticals: Other
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
| % 1. Jan. | Kap. | |
|---|---|---|
| +32,09 % | 694 Mrd. | |
| +29,39 % | 593 Mrd. | |
| -1,34 % | 371 Mrd. | |
| +20,34 % | 331 Mrd. | |
| +7,39 % | 290 Mrd. | |
| +14,25 % | 239 Mrd. | |
| -3,03 % | 209 Mrd. | |
| +10,02 % | 209 Mrd. | |
| +8,49 % | 169 Mrd. |
